TNF and rheumatoid arthritis: Some breakthroughs, including the introduction of anti-tumor necrosis factor alpha (anti-TNF-α), in the treatment of RA, which occurred in the mid-1990s, showed efficacy towards inflammation and joint destruction and led to an improvement of clinical outcomes of RA [3].